- Home
- ATNM vs PHUN Comparison
ATNM vs PHUN Comparison
Compare ATNM & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNM
- PHUN
- Stock Information
- Founded
- ATNM 2000
- PHUN 2009
- Country
- ATNM United States
- PHUN United States
- Employees
- ATNM N/A
- PHUN N/A
- Industry
- ATNM Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- ATNM Health Care
- PHUN Technology
- Exchange
- ATNM Nasdaq
- PHUN Nasdaq
- Market Cap
- ATNM 50.2M
- PHUN 55.9M
- IPO Year
- ATNM N/A
- PHUN N/A
- Fundamental
- Price
- ATNM $1.29
- PHUN $2.32
- Analyst Decision
- ATNM Strong Buy
- PHUN Buy
- Analyst Count
- ATNM 2
- PHUN 2
- Target Price
- ATNM $4.50
- PHUN $7.75
- AVG Volume (30 Days)
- ATNM 306.1K
- PHUN 192.6K
- Earning Date
- ATNM 11-14-2025
- PHUN 11-06-2025
- Dividend Yield
- ATNM N/A
- PHUN N/A
- EPS Growth
- ATNM N/A
- PHUN N/A
- EPS
- ATNM N/A
- PHUN N/A
- Revenue
- ATNM N/A
- PHUN $2,357,000.00
- Revenue This Year
- ATNM N/A
- PHUN N/A
- Revenue Next Year
- ATNM N/A
- PHUN $72.40
- P/E Ratio
- ATNM N/A
- PHUN N/A
- Revenue Growth
- ATNM N/A
- PHUN N/A
- 52 Week Low
- ATNM $1.03
- PHUN $2.21
- 52 Week High
- ATNM $2.41
- PHUN $6.29
- Technical
- Relative Strength Index (RSI)
- ATNM 40.17
- PHUN 39.02
- Support Level
- ATNM $1.23
- PHUN $2.21
- Resistance Level
- ATNM $1.40
- PHUN $2.59
- Average True Range (ATR)
- ATNM 0.09
- PHUN 0.12
- MACD
- ATNM -0.01
- PHUN -0.04
- Stochastic Oscillator
- ATNM 19.61
- PHUN 22.22
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.